Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome

Accumulating evidence has implicated that berberine (BBR) has a beneficial effect on diabetic kidney disease (DKD), but its mechanism is not clear. The aim of this study was to assess whether berberine could alleviate tubulointerstitial fibrosis and attenuate epithelial-to-mesenchymal transition (EM...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zejun, Zhu, Lili, Wang, Shangshang, Guo, Xin, Sun, Bei, Wang, Qilong, Chen, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154812/
https://www.ncbi.nlm.nih.gov/pubmed/35618411
http://dx.doi.org/10.1080/0886022X.2022.2079525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154812/
https://www.ncbi.nlm.nih.gov/pubmed/35618411
http://dx.doi.org/10.1080/0886022X.2022.2079525

Ejemplares similares